At close: 3:27:32 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
115,504.0000
53,997.0000
172,831.0000
34,763.0000
31,253.0000
Operating Expense
182,736.0000
155,722.0000
142,877.0000
121,057.0000
100,968.0000
Operating Income
-67,232.0000
-101,725.0000
29,954.0000
-86,294.0000
-69,715.0000
Net Non Operating Interest Income Expense
22,172.0000
13,014.0000
1,438.0000
-433.0000
561.0000
Other Income Expense
-3,013.0000
-8,283.0000
10,644.0000
-6,608.0000
-142,687.0000
Pretax Income
-48,073.0000
-96,994.0000
42,036.0000
-93,335.0000
-211,841.0000
Tax Provision
7,720.0000
--
4,522.0000
--
--
Net Income Common Stockholders
-60,021.0000
-96,994.0000
37,514.0000
-93,335.0000
-211,284.0000
Diluted NI Available to Com Stockholders
-60,021.0000
-96,994.0000
37,514.0000
-93,335.0000
-211,284.0000
Total Operating Income as Reported
-67,232.0000
-101,725.0000
29,954.0000
-86,294.0000
-69,715.0000
Total Expenses
182,736.0000
155,722.0000
142,877.0000
121,057.0000
100,968.0000
Net Income from Continuing & Discontinued Operation
-55,793.0000
-96,994.0000
37,514.0000
-93,335.0000
-211,284.0000
Normalized Income
-53,231.9500
-88,711.0000
28,015.0226
-86,727.0000
-68,597.0000
Interest Income
23,037.0000
13,845.0000
2,476.0000
133.0000
850.0000
Interest Expense
865.0000
831.0000
1,038.0000
566.0000
289.0000
Net Interest Income
22,172.0000
13,014.0000
1,438.0000
-433.0000
561.0000
EBIT
-47,208.0000
-96,163.0000
43,074.0000
-92,769.0000
-211,552.0000
EBITDA
-36,257.0000
-88,929.0000
50,041.0000
-87,509.0000
-207,128.0000
Reconciled Depreciation
10,951.0000
7,234.0000
6,967.0000
5,260.0000
4,424.0000
Net Income from Continuing Operation Net Minority Interest
-55,793.0000
-96,994.0000
37,514.0000
-93,335.0000
-211,284.0000
Total Unusual Items Excluding Goodwill
-3,013.0000
-8,283.0000
10,644.0000
-6,608.0000
-142,687.0000
Total Unusual Items
-3,013.0000
-8,283.0000
10,644.0000
-6,608.0000
-142,687.0000
Normalized EBITDA
-33,244.0000
-80,646.0000
39,397.0000
-80,901.0000
-64,441.0000
Tax Rate for Calcs
0.0002
--
0.0001
--
--
Tax Effect of Unusual Items
-451.9500
--
1,145.0226
--
--
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WSNAF Wesana Health Holdings Inc.
0.0027
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%
SRZNW Surrozen, Inc.
0.0500
0.00%
TYPTF
0.0280
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0251
0.00%
KRBP Kiromic BioPharma, Inc.
0.9250
0.00%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
CUBT Curative Biotechnology, Inc.
0.0118
+6.31%
REVBW Revelation Biosciences, Inc.
0.0140
+7.69%
TVGNW Tevogen Bio Holdings Inc.
0.0770
-3.23%